Switzerland approves Pfizer-BioNTech Covid-19 vaccine for emergency use, marking global first
Switzerland has become the first country to grant full approval for the Pfizer-BioNTech BNT162b2 Covid-19 vaccine, making a significant move in the global race against ... Read More
Appili Therapeutics begins Phase 3 clinical trial for Avigan in fight against Covid-19
Appili Therapeutics, a Canadian infectious disease biopharmaceutical company, has announced a major milestone in its fight against Covid-19: the commencement of the Phase 3 clinical ... Read More
UK grants emergency authorization for Pfizer and BioNTech’s BNT162b2 Covid-19 vaccine
The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has granted emergency use authorization (EUA) for the BNT162b2 Covid-19 vaccine candidate, developed by Pfizer and ... Read More
Lilly secures $375m deal with US govt for bamlanivimab Covid-19 treatment
Eli Lilly and Company (Lilly), a global pharmaceutical leader, has signed a significant $375 million agreement with the US government for the supply of 300,000 ... Read More
AstraZeneca resumes AZD1222 Covid-19 vaccine trials after safety review
AstraZeneca has announced the resumption of its clinical trials for the AZD1222 Covid-19 vaccine candidate in multiple countries, following confirmation from regulators in the US, ... Read More
Precision Nanosystems secures C$18.2m funding for mRNA COVID-19 vaccine development
Precision Nanosystems (PNI), a Vancouver-based biotechnology company, has secured a significant funding boost of up to CAD 18.2 million from Canada’s Innovation, Science and Economic ... Read More
Remdesivir FDA approval: A milestone in the fight against COVID-19
In a significant development for the medical and pharmaceutical communities, Gilead Sciences, a California-based biopharmaceutical company, has received full approval from the U.S. Food and ... Read More
Oxford University develops rapid diagnostic test for Covid-19 detection in five minutes
A team of scientists from Oxford University's Physics Department has unveiled a groundbreaking diagnostic test capable of detecting and identifying Covid-19 within just five minutes. ... Read More
Novavax begins phase 3 trial of NVX-CoV2373 COVID-19 vaccine candidate
Novavax has initiated its first phase 3 clinical trial to assess the efficacy, safety, and immunogenicity of its NVX-CoV2373 COVID-19 vaccine candidate. The US vaccine ... Read More
J&J begins phase 3 ENSEMBLE Covid-19 vaccine trial for JNJ-78436735
ENSEMBLE Covid-19 vaccine trial : Johnson & Johnson (J&J) has launched a multi-nation phase 3 trial called ENSEMBLE for its JNJ-78436735 Covid-19 vaccine candidate (Ad26.COV2.S), ... Read More